HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Octopirox Data Supports Inclusion In OTC Anti-Dandruff Rule – Clariant

This article was originally published in The Rose Sheet

Executive Summary

The safety and efficacy of dandruff control ingredient piroctone olamine in .05%-.5% and .1%-1% concentrations in leave-on and rinse-off products, respectively, is established by animal and human data, warranting the ingredient's inclusion in the OTC anti-dandruff monograph, according to Clariant
Advertisement

Related Content

FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
Advertisement
UsernamePublicRestriction

Register

RS012610

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel